Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. The company was founded in 1967 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.
Guilinnjin Pharmaceutical Dividend Announcement
• Guilinnjin Pharmaceutical announced a semi annually dividend of ¥0.25 per ordinary share which will be made payable on 2024-11-26. Ex dividend date: 2024-11-26
• Guilinnjin Pharmaceutical annual dividend for 2024 was ¥0.55
• Guilinnjin Pharmaceutical annual dividend for 2023 was ¥0.70
• Guilinnjin Pharmaceutical's trailing twelve-month (TTM) dividend yield is 4.06%
• Guilinnjin Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 98.24%
• Guilinnjin Pharmaceutical's dividend growth over the last five years (2018-2023) was 11.84% year
• Guilinnjin Pharmaceutical's dividend growth over the last ten years (2013-2023) was 3.42% year
Guilinnjin Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-26 | ¥0.25 | semi annually | 2024-11-26 |
2024-05-29 | ¥0.30 | semi annually | 2024-05-29 |
2023-11-27 | ¥0.30 | semi annually | 2023-11-27 |
2023-05-31 | ¥0.40 | semi annually | 2023-05-31 |
2022-12-01 | ¥0.40 | semi annually | 2022-12-01 |
2022-05-30 | ¥0.50 | semi annually | 2022-05-30 |
2021-11-25 | ¥0.40 | semi annually | 2021-11-25 |
2021-06-01 | ¥0.40 | semi annually | 2021-06-01 |
2020-06-01 | ¥0.23 | semi annually | 2020-06-01 |
2019-05-31 | ¥0.35 | semi annually | 2019-05-31 |
2018-05-24 | ¥0.40 | semi annually | 2018-05-24 |
2017-06-12 | ¥0.40 | semi annually | 2017-06-12 |
2016-06-02 | ¥0.50 | semi annually | |
2015-06-02 | ¥0.60 | semi annually | |
2014-04-29 | ¥0.55 | semi annually | |
2013-04-24 | ¥0.50 | semi annually |
Guilinnjin Pharmaceutical Dividend per year
Guilinnjin Pharmaceutical Dividend growth
Guilinnjin Pharmaceutical Dividend Yield
Guilinnjin Pharmaceutical current trailing twelve-month (TTM) dividend yield is 4.06%. Interested in purchasing Guilinnjin Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Guilinnjin Pharmaceutical Financial Ratios
Guilinnjin Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Guilinnjin Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Guilinnjin Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Guilinnjin Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Guilinnjin Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Guilinnjin Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Guilinnjin Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Guilinnjin Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Guilinnjin Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Guilinnjin Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Guilinnjin Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Guilinnjin Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.